|
Originally published In Press as doi:10.1074/jbc.M111145200 on March 27, 2002
J. Biol. Chem., Vol. 277, Issue 25, 22231-22239, June 21, 2002
A Ligand-inducible Epidermal Growth Factor Receptor/Anaplastic
Lymphoma Kinase Chimera Promotes Mitogenesis and Transforming
Properties in 3T3 Cells*
Gina
Piccinini ,
Roberta
Bacchiocchi ,
Michela
Serresi §,
Caterina
Vivani¶,
Silvia
Rossetti ,
Claudia
Gennaretti ,
Damiano
Carbonari , and
Francesca
Fazioli
From the Laboratory of Cellular and
Molecular Biology, Institute of Internal Medicine and ¶ Institute
of Urology, University of Ancona, Via Tronto 10/A,
60020 Ancona, Italy
Oncogenic rearrangements of the anaplastic
lymphoma kinase (ALK) gene, encoding a receptor type tyrosine kinase,
are frequently associated with anaplastic large cell lymphomas.
Such rearrangements juxtapose the intracellular domain of ALK to 5'-end
sequences belonging to different genes and create transforming fusion
proteins. To understand how the oncogenic versions of ALK contribute to lymphomagenesis, it is important to analyze the biological effects and
the biochemical properties of this receptor under controlled conditions
of activation. To this aim, we constructed chimeric receptor molecules
in which the extracellular domain of the ALK kinase is replaced by the
extracellular, ligand-binding domain of the epidermal growth
factor receptor (EGFR). Upon transfection in NIH 3T3
fibroblasts, the EGFR/ALK chimera was correctly synthesized and transported to the cell surface, where it was fully functional in
forming high versus low affinity EGF-binding sites and
transducing an EGF-dependent signal intracellularly.
Overexpression of the EGFR/ALK chimera in NIH 3T3 was sufficient to
induce the malignant phenotype; the appearance of the transformed
phenotype was, however, conditionally dependent on the administration
of EGF. Moreover, the EGFR/ALK chimera was significantly more active in
inducing transformation and DNA synthesis than the wild type EGFR when either was expressed at similar levels in NIH 3T3 cells. Comparative analysis of the biochemical pathways implicated in the transduction of
mitogenic signals did not show any increased ability of the EGFR/ALK to
phosphorylate PLC- and MAPK compared with the EGFR. On the contrary,
EGFR/ALK showed to have a consistently greater effect on
phosphatidylinositol 3-kinase activity compared with the EGFR,
indicating that this enzyme plays a major role in mediating the
mitogenic effects of ALK in NIH 3T3 cells.
*
This work was supported by a grant from the Associazione
Italiana Ricerca sul Cancro.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by a Fellowship from Fondazione Italiana Ricerca Cancro.
To whom correspondence should be addressed. Tel.:
39-071-2206144; Fax: 39-071-2206125; E-mail:
fazioli@popcsi.unian.it.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Schalk-Hihi, H.-C. Ma, G. T. Struble, S. Bayoumy, R. Williams, E. Devine, I. P. Petrounia, T. Mezzasalma, L. Zeng, C. Schubert, et al.
Protein Engineering of the Colony-stimulating Factor-1 Receptor Kinase Domain for Structural Studies
J. Biol. Chem.,
February 9, 2007;
282(6):
4085 - 4093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bacchiocchi, G. Baldanzi, D. Carbonari, C. Capomagi, E. Colombo, W. J. van Blitterswijk, A. Graziani, and F. Fazioli
Activation of {alpha}-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase
Blood,
September 15, 2005;
106(6):
2175 - 2182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Motegi, J. Fujimoto, M. Kotani, H. Sakuraba, and T. Yamamoto
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth
J. Cell Sci.,
July 1, 2004;
117(15):
3319 - 3329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. T. Bowden, G. E. Stoica, and A. Wellstein
Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma Kinase
J. Biol. Chem.,
September 20, 2002;
277(39):
35862 - 35868.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|